Company Overview of RxGen, Inc.
RxGen, Inc. operates as a translational research company. It develops in vivo disease models to evaluate, select, and develop candidate therapeutics and drug delivery technologies. The company offers preclinical research models and services focusing on central nervous system, ophthalmic, and metabolic disorders. RxGen, Inc. is based in Hamden, Connecticut.
100 Deepwood Drive
Hamden, CT 06517
Key Executives for RxGen, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Sponsored Financial Commentaries
To contact RxGen, Inc., please visit www.rx-gen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.